KEYNOTE-061: Phase 3 study of pembrolizumab vs paclitaxel for previously treated advanced gastric or gastroesophageal junction (G/GEJ) cancer


Shitara K., Ozguroglu M., Bang Y. J. , Di Bartolomeo M., Mandala M., Ryu M. H. , ...More

ESMO 20th World Congress on Gastrointestinal Cancer, Barcelona, Spain, 20 - 23 June 2018, vol.29 identifier

  • Publication Type: Conference Paper / Summary Text
  • Volume: 29
  • City: Barcelona
  • Country: Spain